Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dylan C Dean

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 23, 2019
Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathwayShen Shen, Dylan C Dean, Zujiang Yu, et al.
Cancer Metastasis Reviews|September 1, 2018
From genomics to metabolomics: emerging metastatic biomarkers in osteosarcomaDylan C Dean, Shen Shen, Francis J Hornicek, et al.
Molecular Cancer|August 15, 2019
Exosomes promote pre-metastatic niche formation in ovarian cancerWenlong Feng, Dylan C Dean, Francis J Hornicek, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2019
Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancerJinglu Wang, Dylan C Dean, Francis J Hornicek, et al.
Cancer Letters|January 29, 2020
Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapyJie Zhao, Dylan C Dean, Francis J Hornicek, et al.
Bioscience Reports|January 5, 2022
SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcomaTao Guo, Ran Wei, Dylan C Dean, et al.
Therapeutic Advances in Musculoskeletal Disease|June 9, 2021
Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcomaHangzhan Ma, Dylan C Dean, Ran Wei, et al.
Gynecologic Oncology|October 10, 2018
RNA sequencing (RNA-Seq) and its application in ovarian cancerJinglu Wang, Dylan C Dean, Francis J Hornicek, et al.
Journal of Bone Oncology|February 19, 2019
Advances in immune checkpoint inhibitors for bone sarcoma therapyPichaya Thanindratarn, Dylan C Dean, Scott D Nelson, et al.
Cell Proliferation|September 22, 2020
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in ChordomaPichaya Thanindratarn, Dylan C Dean, Scott D Nelson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 23, 2019
Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathwayShen Shen, Dylan C Dean, Zujiang Yu, et al.
Cancer Metastasis Reviews|September 1, 2018
From genomics to metabolomics: emerging metastatic biomarkers in osteosarcomaDylan C Dean, Shen Shen, Francis J Hornicek, et al.
Molecular Cancer|August 15, 2019
Exosomes promote pre-metastatic niche formation in ovarian cancerWenlong Feng, Dylan C Dean, Francis J Hornicek, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2019
Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancerJinglu Wang, Dylan C Dean, Francis J Hornicek, et al.
Cancer Letters|January 29, 2020
Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapyJie Zhao, Dylan C Dean, Francis J Hornicek, et al.
Bioscience Reports|January 5, 2022
SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcomaTao Guo, Ran Wei, Dylan C Dean, et al.
Therapeutic Advances in Musculoskeletal Disease|June 9, 2021
Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcomaHangzhan Ma, Dylan C Dean, Ran Wei, et al.
Gynecologic Oncology|October 10, 2018
RNA sequencing (RNA-Seq) and its application in ovarian cancerJinglu Wang, Dylan C Dean, Francis J Hornicek, et al.
Journal of Bone Oncology|February 19, 2019
Advances in immune checkpoint inhibitors for bone sarcoma therapyPichaya Thanindratarn, Dylan C Dean, Scott D Nelson, et al.
Cell Proliferation|September 22, 2020
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in ChordomaPichaya Thanindratarn, Dylan C Dean, Scott D Nelson, et al.
Pageof 3